Top 10 stocks for today — 15th November 2022

The Nifty futures contract on the Singapore Exchange increased by 60 points, or 0.33%, to trade at 18,437.5, indicating that the stock markets may open Tuesday on a positive note. The following 10 stocks may show price movement in today’s market. To check more hot stocks, click at: https://www.indiainfoline.com/markets/hot-stocks

1. Biocon:

The biotechnology company reported that an increase in total expenses was to blame for its consolidated net profit before exceptional items declining by 11% to Rs168 crore in the second quarter that ended on September 30, 2022.

1. NMDC:

In the three months that ended in September, the state-owned metal company reported a consolidated net profit after tax that fell by 62% YoY to Rs 885.65 crore, primarily due to lower revenue.

1. Brigade Enterprises:

The real estate company reported that its consolidated net profit for the three months ending in September was Rs52 crore as opposed to a net loss of Rs14 crore during the same time last year.

1. SpiceJet:

As a result of high fuel prices and the weakening currency, the airline company’s net loss widened to Rs 837.8 crore in the three months that ended in September.

1. PB Fintech:

According to the bulk deal data available with NSE, Tiger Global Management sold 1,34,17,607 shares, or 2.98% of the parent company of Policybazaar, at an average price of Rs389.38 to Rs389.44 each for Rs522.50 crore.

1. Apollo Tyres:

The major tyre company reported that strong sales in both domestic and foreign markets helped its consolidated net profit for the second quarter that ended in September rise by 11% to Rs194 crore.

1. Ramky Infrastructure:

For the quarter that ended September 30, 2022, the civil construction company reported a 7% increase in consolidated net profit to Rs 51.97 crore.

1. Strides Pharma Science:

For the second quarter that concluded on September 30, 2022, the pharmaceutical company declared a combined net profit of Rs33 lakh.

1. New Delhi Television:

The open offer by Adani Group to acquire an additional 26% share in media company NDTV has been approved by the markets regulator Sebi, and it will go live on November 22.

1. Alembic Pharmaceuticals:

Its Cyclophosphamide capsules, which are used to treat various cancers, have been approved for sale in the US market, according to the medicine manufacturer.

For feedback and suggestions, write to us at editorial@iifl.com